What is a stock summary page? Click here for an overview.
Business Description
Kronos Bio Inc
NAICS : 541714
SIC : 2833
ISIN : US50107A1043
Share Class Description:
KRON: Ordinary SharesDescription
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.52 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -7.08 | |||||
| Beneish M-Score | -1.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 27.8 | |||||
| 3-Year EPS without NRI Growth Rate | 30.2 | |||||
| 3-Year FCF Growth Rate | 21.3 | |||||
| 3-Year Book Growth Rate | -38.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.78 | |||||
| 9-Day RSI | 29.46 | |||||
| 14-Day RSI | 33.07 | |||||
| 3-1 Month Momentum % | 5.99 | |||||
| 6-1 Month Momentum % | 2.14 | |||||
| 12-1 Month Momentum % | -18.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.54 | |||||
| Quick Ratio | 7.54 | |||||
| Cash Ratio | 7.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.8 | |||||
| Shareholder Yield % | 6.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -644.11 | |||||
| Net Margin % | -874.08 | |||||
| FCF Margin % | -664.52 | |||||
| ROE % | -69.65 | |||||
| ROA % | -51.55 | |||||
| ROIC % | -184.18 | |||||
| 3-Year ROIIC % | -235.78 | |||||
| ROC (Joel Greenblatt) % | -320.66 | |||||
| ROCE % | -42.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.26 | |||||
| PB Ratio | 0.6 | |||||
| Price-to-Tangible-Book | 0.6 | |||||
| EV-to-EBIT | 0.56 | |||||
| EV-to-Forward-EBIT | -0.07 | |||||
| EV-to-EBITDA | 0.58 | |||||
| EV-to-Revenue | -3.61 | |||||
| EV-to-FCF | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 0.66 | |||||
| Price-to-Net-Cash | 0.69 | |||||
| Earnings Yield (Greenblatt) % | 178.57 | |||||
| FCF Yield % | -124.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KRON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Kronos Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.848 | ||
| EPS (TTM) ($) | -1.43 | ||
| Beta | 1.88 | ||
| 3-Year Sharpe Ratio | -0.61 | ||
| 3-Year Sortino Ratio | -0.85 | ||
| Volatility % | 76.02 | ||
| 14-Day RSI | 33.07 | ||
| 14-Day ATR ($) | 0.055837 | ||
| 20-Day SMA ($) | 0.92205 | ||
| 12-1 Month Momentum % | -18.06 | ||
| 52-Week Range ($) | 0.69 - 1.6 | ||
| Shares Outstanding (Mil) | 60.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kronos Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kronos Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kronos Bio Inc Frequently Asked Questions
What is Kronos Bio Inc(KRON)'s stock price today?
The current price of KRON is $0.86. The 52 week high of KRON is $1.60 and 52 week low is $0.69.
When is next earnings date of Kronos Bio Inc(KRON)?
The next earnings date of Kronos Bio Inc(KRON) is 2025-05-09 Est..
Does Kronos Bio Inc(KRON) pay dividends? If so, how much?
Kronos Bio Inc(KRON) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers